British Business Bank has previously co-invested in EQT's fund portfolio companies Phagenesis and Cyted Health.

GE HealthCare and Catholic Health have signed a 10-year strategic alliance valued at around $500m, aimed at expanding access to precision diagnostics, advanced imaging, and AI-supported technology ...

Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair.

RapidPulse has secured $48m to advance the clinical development of its aspiration technology to treat acute ischaemic stroke.

HistoSonics will now initiate a phased commercial rollout of its Edison system across European centres of excellence that specialise in liver tumour treatment.

Neko Health has raised $700m, setting the company up with proceeds to scale its full-body scanning service ahead of the planned launch of its first US clinics this year. Putting its funds raised to ...

Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.

Philips has expanded its ultrasound portfolio with the launch of the Alturion system, which features AI-powered workflows and is intended for high-volume clinical environments.

The funds will support the construction of a new manufacturing facility and make significant upgrades to Otsuka ICU Medical's existing manufacturing site in Austin, Texas.

Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation.

VB Spine has signed a definitive agreement with Augmedics to acquire the exclusive rights to the CT-Fluoro technology for spine applications.

The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for cataract patients.